First Command Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
4,617
-1,502
-25% -$323K 0.01% 83
2026
Q1
$1.33M Sell
6,119
-1,305
-18% -$289K 0.01% 76
2025
Q4
$1.7M Buy
7,424
+290
+4% +$66.1K 0.01% 63
2025
Q3
$1.65M Buy
7,134
+285
+4% +$58K 0.01% 63
2025
Q2
$1.27M Sell
6,849
-308
-4% -$57.2K 0.01% 69
2025
Q1
$1.5M Buy
7,157
+350
+5% +$68K 0.01% 58
2024
Q4
$1.21M Buy
6,807
+1,282
+23% +$236K 0.01% 65
2024
Q3
$1.09M Sell
5,525
-182
-3% -$34K 0.01% 72
2024
Q2
$979K Buy
+5,707
New +$945K 0.01% 66
2024
Q1
Sell
-5,322
Closed -$825K 566
2023
Q4
$825K Buy
5,322
+471
+10% +$68.7K 0.01% 70
2023
Q3
$723K Buy
+4,851
New +$712K 0.01% 71
2023
Q2
Sell
-100
Closed -$15.9K 63
2023
Q1
$15.9K Buy
+100
New +$15.3K ﹤0.01% 22
2022
Q3
Sell
-59
Closed 41
2022
Q2
$0 Buy
+59
New +$9.02K ﹤0.01% 69
2021
Q4
Sell
-21
Closed -$2K 42
2021
Q3
$2K Buy
+21
New +$2.4K ﹤0.01% 27

Other funds holding ABBV

First Command Advisory Services's ABBV Position: Q2 2026 in Review

First Command Advisory Services reduced its AbbVie (ABBV) stake by 25% in Q2 2026, selling an estimated $323K and leaving 4,617 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #83.

First Command Advisory Services first reported a position in ABBV in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.7M in Q4 2025. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Command Advisory Services held 4,617 shares of AbbVie worth $1.16M as of Q2 2026.
  • First Command Advisory Services sold 1,502 AbbVie shares in Q2 2026, an estimated $323K.
  • AbbVie made up 0.01% of First Command Advisory Services's portfolio in Q2 2026, its #83 holding.
  • First Command Advisory Services first reported a position in AbbVie in Q3 2021 and has held it in 14 quarters since.
  • First Command Advisory Services's AbbVie position peaked at $1.7M in Q4 2025.
  • 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.